There is a risk that patients who receive the affected product may receive double the dose of IV levetiracetam than what was intended. Dr. Reddy’s Laboratories is recalling 1 batch of Levetiracetam in ...
HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as “Dr. Reddy’s”), is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results